Skip to main content
. 2024 Dec 1;24(6):1785–1794. doi: 10.17305/bb.2024.10512

Figure S3.

Figure S3.

Kaplan–Meier overall survival estimate according to tyrosine kinase inhibitor response (long-term vs short-term) in all patients in good risk (A) and intermediate-poor risk (B). TKI: Tyrosine kinase inhibitor; PFS: Progression-free survival.